GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Herbal Biotechnology Co Ltd (ROCO:4911) » Definitions » Scaled Net Operating Assets

G&E Herbal Biotechnology Co (ROCO:4911) Scaled Net Operating Assets : 0.53 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is G&E Herbal Biotechnology Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

G&E Herbal Biotechnology Co's operating assets for the quarter that ended in Mar. 2024 was NT$559.0 Mil. G&E Herbal Biotechnology Co's operating liabilities for the quarter that ended in Mar. 2024 was NT$92.1 Mil. G&E Herbal Biotechnology Co's Total Assets for the quarter that ended in Dec. 2023 was NT$883.1 Mil. Therefore, G&E Herbal Biotechnology Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.53.


G&E Herbal Biotechnology Co Scaled Net Operating Assets Historical Data

The historical data trend for G&E Herbal Biotechnology Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Herbal Biotechnology Co Scaled Net Operating Assets Chart

G&E Herbal Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.80 0.81 0.71 0.58

G&E Herbal Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.69 0.70 0.58 0.53

Competitive Comparison of G&E Herbal Biotechnology Co's Scaled Net Operating Assets

For the Biotechnology subindustry, G&E Herbal Biotechnology Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G&E Herbal Biotechnology Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G&E Herbal Biotechnology Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where G&E Herbal Biotechnology Co's Scaled Net Operating Assets falls into.



G&E Herbal Biotechnology Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

G&E Herbal Biotechnology Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(570.171-114.429)/782.775
=0.58

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=883.095 - 312.924
=570.171

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=119.86 - 1.294 - 4.137
=114.429

G&E Herbal Biotechnology Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(559.01-92.051)/883.095
=0.53

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=880.25 - 321.24
=559.01

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=97.369 - 1.12 - 4.198
=92.051

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G&E Herbal Biotechnology Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of G&E Herbal Biotechnology Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


G&E Herbal Biotechnology Co (ROCO:4911) Business Description

Traded in Other Exchanges
N/A
Address
No.92, Keji 5th Road, Annan District, Tainan City, TWN, 70995
G&E Herbal Biotechnology Co Ltd is a Taiwan based biopharmaceutical company. It is specialized in the production of western conventional drugs, Chinese traditional drugs, unclassified food, cosmetics, and health products. The company is focused on botanical extraction technology and products. Its products include botanical extract toner, total moisture conditioning cream, whitening clear cream and firming essence cream.

G&E Herbal Biotechnology Co (ROCO:4911) Headlines

No Headlines